Table of Contents page: European Journal of Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial

M. Ekholm,
P.O. Bendahl,
M. Fernö,
...
O. Stål,
L. Rydén
on behalf of the South Swedish and South-East Swedish Breast Cancer Groups

Published online: February 12, 2019

p53-61

Open Access

Role of thoracic consolidation radiation in extensive stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials

Shrinivas Rathod,
Branislav Jeremic,
Arbind Dubey,
...
Sandra Pereira,
JaiPrakash Agarwal,
Rashmi Koul

Published online: February 18, 2019

p110-119

Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial

Gianluca Masi,
Caterina Vivaldi,
Lorenzo Fornaro,
...
Antonello Di Paolo,
Vittorina Zagonel,
Alfredo Falcone

Published online: February 07, 2019

p32-41

Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma

Xiao-Yun Li,
Qiu-Yan Chen,
Xue-Song Sun,
...
Jun Ma,
Lin-Quan Tang,
Hai-Qiang Mai

Published online: February 07, 2019

p24-31

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma

W. van Boxtel,
L.D. Locati,
A.C.H. van Engen-van Grunsven,
...
L. Licitra,
C.M.L. van Herpen
PALGA Group

Published online: February 13, 2019

p62-70

Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases

Ricarda Rauschenberg,
Johannes Bruns,
Julia Brütting,
...
Jennifer Linn,
Esther G.C. Troost,
Friedegund Meier

Published online: February 07, 2019

p11-20

Open Access

ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children

Andrew D.J. Pearson,
Nicole Scobie,
Koenraad Norga,
...
Su Young Kim,
Gregory Reaman,
Gilles Vassal

Published online: February 14, 2019

p74-85

Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors

Andrea Ferrari,
Ines B. Brecht,
Gemma Gatta,
...
Andrea Biondi,
Gianni Bisogno,
Annalisa Trama

Published online: February 19, 2019

p120-126

Avoidable cancers in the Nordic countries—the potential impact of increased physical activity on postmenopausal breast, colon and endometrial cancer

Therese M-L. Andersson,
Gerda Engholm,
Anne-Sofie Q. Lund,
...
Laufey Tryggvadottir,
Elisabete Weiderpass,
Hans Storm

Published online: February 07, 2019

p42-48

Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry

Francesca Bagnasco,
Silvia Caruso,
Anita Andreano,
...
Julianne Byrne,
Riccardo Haupt
for the OTR-AIEOP Registry

Published online: February 14, 2019

p86-97

Increased survival of non low-grade and deep-seated soft tissue sarcoma after surgical management in high-volume hospitals: a nationwide study from the Netherlands

Melissa Vos,
Harriët G.T. Blaauwgeers,
Vincent K.Y. Ho,
...
Dirk J. Grünhagen,
Cornelis Verhoef
on behalf of the Dutch Sarcoma Study Group (DSSG)

Published online: February 16, 2019

p98-106

Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015

N. Grössmann,
M. Robausch,
K. Rosian,
C. Wild,
J. Simon

Published online: February 05, 2019

p1-7

Open Access

Prurigo nodularis and pembrolizumab: A therapeutic challenge

Davide Fattore,
Luigia Panariello,
Maria Carmela Annunziata,
Gabriella Fabbrocini

Published online: February 05, 2019

p8-10

Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab

Martin Dutertre,
Mathilde de Menthon,
Nicolas Noël,
Laurence Albiges,
Olivier Lambotte

Published online: February 07, 2019

p21-23

A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia

Mathilde Berger,
Mona Amini-Adlé,
Laura Crumbach,
Etienne Paubelle,
Stéphane Dalle

Published online: February 08, 2019

p49-52

Mitochondrial myopathy associated with anti-programmed cell death 1 therapy

Tony Ibrahim,
Clovis Adam,
Emilie Routier,
Abdelhamid Slama,
Caroline Robert

Published online: February 14, 2019

p71-73

Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast

Davide Fattore,
Maria Carmela Annunziata,
Luigia Panariello,
Claudio Marasca,
Gabriella Fabbrocini

Published online: February 18, 2019

p107-109

March 2019

Breast cancer

Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial

Lung cancer

Role of thoracic consolidation radiation in extensive stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials

Gastrointestinal oncology

Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial

Head and neck oncology

Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma

Melanoma and skin cancers

Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases

Pediatric oncology

ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children

Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors

Epidemiology and prevention

Avoidable cancers in the Nordic countries—the potential impact of increased physical activity on postmenopausal breast, colon and endometrial cancer

Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry

Increased survival of non low-grade and deep-seated soft tissue sarcoma after surgical management in high-volume hospitals: a nationwide study from the Netherlands

Other

Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015

Correspondence

Prurigo nodularis and pembrolizumab: A therapeutic challenge

Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab

A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia

Mitochondrial myopathy associated with anti-programmed cell death 1 therapy

Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast